PD Dr. Norbert Meidenbauer

Medizinische Fakultät Department of Medicine 5 – Haematology and Oncology

Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022) Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Conference contribution Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial (2022) Zimmermann H, Koenecke C, Dreyling MH, Pott C, Duehrsen U, Hahn D, Meidenbauer N, et al. Journal article New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial (2022) Schlichtig K, Cuba L, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Journal article Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial (2021) Zimmermann H, Koenecke C, Dreyling MH, Pott C, Duhrsen U, Hahn D, Meidenbauer N, et al. Conference contribution Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome (2021) Willner A, Fechner K, Agaimy A, Haller F, Eckstein M, Ott O, Putz F, et al. Journal article Treatment strategy by radioiodine refractory differentiated thyroid cancer (2021) Mantsopoulos K, Müller SK, Pavel ME, Kuwert T, Meidenbauer N, Fietkau R, Sievert M, Iro H Journal article Rituximab for treatment of T-cell large granular lymphocytic leukaemia associated with rheumatoid arthritis (2021) Meintker L, Mackensen A, Meidenbauer N, Ferstl B Conference contribution Assessment of educational and social status of survivors of childhood cancer: Data of a single center late effects clinic (2021) Hahn B, Schuster S, Metzler M, Mackensen A, Meidenbauer N Conference contribution Beta-HCG elevation as first sign of a malignant somatic transformation of a non-seminomatous germ cell tumor (2021) Peuser M, Hartmann A, Schmidt D, Mackensen A, Meidenbauer N Conference contribution Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot (2021) Agaimy A, Meidenbauer N, Sukov WR, Stöhr R, Vieth M, Roemer F, Grützmann R, Folpe AL Journal article